Viewing nowEmpagliflozin 10 mg Tablets
Empagliflozin 10mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

MFDS item code 202102283 · Approved 2021.03.12 · Insurance code 698504900
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar levels in adults with type 2 diabetes. It can be initiated as monotherapy, but if blood sugar control is insufficient, it should be used in combination with metformin, pioglitazone, sulfonylureas, insulin, or the DPP-4 inhibitor linagliptin. Caution is particularly advised in patients with cardiovascular disease, and it is important to follow the guidance of a healthcare professional. This medication can effectively improve blood sugar control.
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited
This medication should not be used in certain patients. First, it should not be administered to patients with allergies to the active ingredient or any of the components of this medication. Additionally, it may be risky for patients with type 1 diabetes or diabetic ketoacidosis to use this medication. It should not be administered to patients with severely impaired renal function, defined as a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m² or those with end-stage renal disease or on dialysis. As this medication contains lactose, it should not be used in patients with lactose intolerance, galactose intolerance, or certain genetic lactose-related disorders. Patients with moderately impaired renal function should use this medication with caution, and renal function should be monitored regularly to adjust the dosage or discontinue if necessary. In cases of mild to moderate heart failure, the medication should be used cautiously, and it is not recommended for patients with severe heart failure. When used in combination with insulin or sulfonylureas, there may be a risk of hypoglycemia, necessitating dosage adjustments. During the use of this medication, there may be instances of hypoglycemia when combined with sulfonylureas or insulin, so caution is required. There may be an increased risk of infections, such as genital fungal infections in women and urinary tract infections in both men and women, so immediate treatment is necessary when symptoms arise. This medication may increase urination frequency, which can lead to dehydration or low blood pressure, so caution is particularly required for the elderly or patients with low blood pressure. Serious metabolic disturbances known as ketoacidosis can occur; therefore, if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing appear, immediate medical attention is required. There have also been reports of liver damage, so any manifestations of abnormal liver function should be discussed with a physician. There may be limitations on methods for monitoring blood sugar control during the use of this medication, so it is essential to follow instructions from a healthcare provider. It is recommended that women who are pregnant or planning to become pregnant do not use this medication, and it should also be avoided during breastfeeding. The safety and efficacy of this medication in children under 18 years of age have not been established. No specific toxicity has been reported in cases of overdose, but appropriate treatment should be administered based on clinical symptoms. This medication should be stored out of reach of children, and transferring it to other containers is not good for maintaining its quality. Caution is required when driving or operating machinery due to the risk of hypoglycemia. Moreover, diabetic patients should ensure thorough foot care as a preventive measure, and if there is pain or any unusual symptoms in the perineal area, they must seek medical attention immediately.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to avoid exposure to air and moisture. It is best kept at room temperature between 1 to 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer period.
Light yellow, biconvex, round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 10mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.